Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06535867 · ClinicalTrials.gov registry record

The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

A clinical trial of Smoking and Alcohol Drinking, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
5,122
Enrollment target
1
Study location

NCT06535867: Recruiting study of Smoking and Alcohol Drinking, sponsored by Memorial Sloan Kettering Cancer Center.

NCT06535867 is a study of Smoking and Alcohol Drinking that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 5,122 participants, above the 413-participant average among 123 other Smoking trials with a reported enrollment target (1140% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06535867, a study of Smoking and Alcohol Drinking, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
5,122 participants
Enrollment target
1
Study location

Study Summary

Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral cancer in India

Primary Outcome

To compare the efficacy of conventional screening with mHealth in identification of oral potentially malignant disorders (OPMDs) / oral cancer.

Interventions

  • DIAGNOSTIC_TEST mHealth

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center (All protocol activites) - New York

Trial Details

FieldValue
Enrollment Target 5,122 participants
Start Date 2024-07-30
Est. Completion 2031-07-30
Memorial Sloan Kettering Cancer Center

1,884 total trials

What NCT06535867 shows while recruiting

NCT06535867 is an observational study that tracks outcomes without assigning an intervention. Its 5,122 participants enrollment target places it among the larger protocols in the corpus, above the 413-participant average among 123 other Smoking trials with a reported enrollment target (1140% higher).

The record links to 8 conditions, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which mHealth is the first listed.

NCT06535867 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06535867 about?

NCT06535867 is a clinical study titled "The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study". Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral ...

What is the current status of trial NCT06535867?

This trial is currently recruiting. The enrollment target is 5,122 participants. The study started on 2024-07-30. Estimated completion is 2031-07-30.

What conditions does trial NCT06535867 study?

This clinical trial studies the following conditions: Smoking, Alcohol Drinking, Tobacco Use, Tobacco Smoking, Smoking, Cigarette.

What interventions are being tested in trial NCT06535867?

The interventions under investigation include: mHealth (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06535867?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06535867 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06535867's enrollment target sits among peer trials

5,122 1st of 123 higher than 123 of 123 other Smoking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05018611 · 5,100 participants · NA

    Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

  • NCT05701358 · 5,100 participants · NA

    Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  • NCT06292078 · 5,076 participants · NA

    Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

  • NCT05135403 · 5,179 participants

    ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06535867, the US trial registry maintained by the National Library of Medicine. NCT06535867 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.